Home › Exclusive: Hospira Wins French Biosimilar Drug Tender At 45 Percent Discount
 

Keywords :   


Exclusive: Hospira Wins French Biosimilar Drug Tender At 45 Percent Discount

2015-07-04 01:46:09| Biotech - Topix.net

A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis, Crohn's disease and psoriasis in a victory for a new type of medicine known as biosimilars. In a document seen by Reuters, the central purchasing agency for the Assistance Publique - HA pitaux de Paris said on Friday it had decided to buy the biosimilar version of infliximab from Hospira, after the company offered a discount of some 45 percent to branded Remicade.

Tags: french drug percent discount

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Graphics
More »